# NAUT (Nautilus Biotechnology, Inc.) - SEC EDGAR Financial Statements

> Nautilus Biotechnology, Inc. reported $148.9M in total assets and a net loss of $58.58M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/NAUT
- Markdown: https://convexityos.com/fundamentals/NAUT.md
- SEC CIK: 0001808805
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:41 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001808805&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -- | Operating profit |
| Net Income | FY 2025 | -$58.58M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.46 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$55.13M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $86.58M | Total debt: $26.74M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $41.11M | $50.48M | $47.25M | $37.67M | $29.35M | $12.43M |
| Total Operating Expenses | $66.84M | $81.48M | $76.15M | $63.62M | $50.50M | $15.74M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$59.00M | -$70.78M | -$63.67M | -$57.92M | -$50.31M | -$15.62M |
| Basic EPS | -$0.47 | -$0.56 | -$0.51 | -$0.46 | -$0.60 | -$0.54 |
| **Diluted EPS** | -$0.47 | -$0.56 | -$0.51 | -$0.46 | -$0.60 | -$0.54 |
| Basic Shares Outstanding | 126.3M | 125.4M | 124.9M | 124.6M | 84.5M | 29.1M |
| Diluted Shares Outstanding | 126.3M | 125.4M | 124.9M | 124.6M | 84.5M | 29.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $234K | $190K | -- | -- | $0 | $0 | -- | -- |
| Cost of Revenue | $24K | $15K | -- | -- | $0 | $0 | -- | -- |
| **Gross Profit** | $210K | $175K | -- | -- | $0 | $0 | -- | -- |
| Research & Development | $10.18M | $9.61M | $9.71M | $9.57M | $9.61M | $10.39M | $11.54M | $12.82M |
| Selling, General & Admin | $6.77M | $6.33M | $6.42M | -- | $5.87M | $6.70M | $7.31M | -- |
| Total Operating Expenses | $16.95M | $15.94M | $16.12M | $15.42M | $15.47M | $17.10M | $18.84M | $19.98M |
| **Operating Income** | -$16.74M | -$15.76M | -- | -- | -$15.47M | -$17.10M | -- | -- |
| **EBITDA** | -$16.54M | -$15.46M | -- | -- | -$15.07M | -$16.70M | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$15.64M | -$14.47M | -$14.70M | -$13.78M | -$13.57M | -$15.03M | -$16.61M | -$17.59M |
| Basic EPS | -$0.12 | -$0.11 | -$0.12 | -- | -$0.11 | -$0.12 | -$0.13 | -- |
| **Diluted EPS** | -$0.12 | -$0.11 | -$0.12 | -- | -$0.11 | -$0.12 | -$0.13 | -- |
| Basic Shares Outstanding | 127.2M | 127.1M | 126.6M | -- | 126.3M | 126.2M | 126.1M | -- |
| Diluted Shares Outstanding | 127.2M | 127.1M | 126.6M | -- | 126.3M | 126.2M | 126.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $12.39M | $27.65M | $19.40M | $114.5M | $185.6M | $36.61M |
| Short-Term Investments | $91.02M | $102.2M | $154.0M | $69.95M | $160.1M | $40.13M |
| **Cash & Short-Term Investments** | $103.4M | $129.9M | $173.4M | $184.5M | $345.7M | $76.74M |
| **Total Current Assets** | $106.0M | $132.8M | $176.8M | $187.2M | $349.2M | $77.66M |
| Property, Plant & Equipment, Net | $3.46M | $4.08M | $4.27M | $3.70M | $2.48M | $1.37M |
| Long-Term Investments | $52.74M | $76.41M | $90.65M | $129.2M | $16.37M | $0 |
| Other Non-Current Assets | $1.18M | $1.18M | $1.18M | $1.11M | $997K | $1.14M |
| **Total Non-Current Assets** | $85.15M | $109.9M | $128.7M | $162.8M | $49.23M | $7.35M |
| **Total Assets** | $191.1M | $242.7M | $305.6M | $350.1M | $398.4M | $85.01M |
| Accounts Payable | $943K | $987K | $1.64M | $1.27M | $1.72M | $470K |
| **Total Current Liabilities** | $7.95M | $7.63M | $9.12M | $6.79M | $5.81M | $3.02M |
| **Total Non-Current Liabilities** | $26.19M | $26.38M | $31.09M | $28.34M | $29.06M | $3.30M |
| **Total Liabilities** | $34.14M | $34.01M | $40.21M | $35.13M | $34.87M | $6.31M |
| **Total Debt (incl. Leases)** | $30.02M | $30.48M | $34.63M | $30.33M | $30.03M | $4.78M |
| Common Stock | $13K | $13K | $13K | $12K | $12K | $1.0K |
| Retained Earnings | -$332.0M | -$273.0M | -$202.2M | -$138.6M | -$80.64M | -$30.32M |
| Accumulated Other Comp. Income | $243K | $57K | -$255K | -$1.85M | -$184K | $3.0K |
| **Total Stockholders' Equity** | $157.0M | $208.7M | $265.4M | $314.9M | $363.6M | -$29.72M |
| Total Equity | $157.0M | $208.7M | $265.4M | $314.9M | $363.6M | -$29.72M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $10.47M | $13.17M | $14.63M | $12.39M | $23.88M | $34.46M | $33.24M | $27.65M |
| Short-Term Investments | $76.11M | $70.86M | $81.24M | $91.02M | $107.6M | $113.4M | $105.6M | $102.2M |
| **Cash & Short-Term Investments** | $114.3M | $84.00M | $95.90M | $103.4M | $131.4M | $147.9M | $138.8M | $129.9M |
| Inventory | $900K | $600K | $300K | -- | -- | -- | -- | -- |
| **Total Current Assets** | $90.24M | $87.63M | $98.83M | $106.0M | $134.3M | $150.7M | $141.6M | $132.8M |
| Property, Plant & Equipment, Net | $5.27M | $4.00M | $3.63M | $3.46M | $3.62M | $3.73M | $3.79M | $4.08M |
| Long-Term Investments | $27.77M | $45.16M | $47.51M | $52.74M | $37.06M | $31.64M | $54.02M | $76.41M |
| Other Non-Current Assets | $1.06M | $1.18M | $1.18M | $1.18M | $1.18M | $1.18M | $1.18M | $1.18M |
| **Total Non-Current Assets** | $58.69M | $75.95M | $78.95M | $85.15M | $66.59M | $62.46M | $86.09M | $109.9M |
| **Total Assets** | $148.9M | $163.6M | $177.8M | $191.1M | $200.9M | $213.2M | $227.7M | $242.7M |
| Accounts Payable | $1.26M | $1.09M | $1.19M | $943K | $893K | $974K | $841K | $987K |
| **Total Current Liabilities** | $9.76M | $8.64M | $8.34M | $7.95M | $8.98M | $8.14M | $8.16M | $7.63M |
| **Total Non-Current Liabilities** | $22.61M | $23.82M | $25.02M | $26.19M | $22.79M | $23.96M | $25.10M | $26.38M |
| **Total Liabilities** | $32.37M | $32.46M | $33.36M | $34.14M | $31.78M | $32.09M | $33.26M | $34.01M |
| **Total Debt (incl. Leases)** | $26.74M | $27.82M | $28.87M | $30.02M | $27.00M | $28.18M | $29.34M | $30.48M |
| Common Stock | $13K | $13K | $13K | $13K | $13K | $13K | $13K | $13K |
| Retained Earnings | -$376.8M | -$361.2M | -$346.7M | -$332.0M | -$318.2M | -$304.7M | -$289.6M | -$273.0M |
| Accumulated Other Comp. Income | -$572K | -$331K | -$91K | $243K | $200K | $77K | $189K | $57K |
| **Total Stockholders' Equity** | $116.6M | $131.1M | $144.4M | $157.0M | $169.1M | $181.1M | $194.4M | $208.7M |
| Total Equity | $116.6M | $131.1M | $144.4M | $157.0M | $169.1M | $181.1M | $194.4M | $208.7M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$59.00M | -$70.78M | -$63.67M | -$57.92M | -$50.31M | -$15.62M |
| Depreciation & Amortization | $1.70M | $2.00M | $1.85M | $1.22M | $1.02M | $710K |
| Stock-Based Compensation | $6.84M | $12.70M | $12.14M | $10.38M | $7.93M | $369K |
| Change in Payables | -$69K | -$578K | $393K | -$561K | $1.26M | $123K |
| **Operating Cash Flow** | -$50.70M | -$59.15M | -$51.71M | -$45.81M | -$39.24M | -$14.00M |
| Capital Expenditure | -$1.28M | -$2.12M | -$2.44M | -$2.32M | -$2.27M | -$921K |
| **Free Cash Flow** | -$51.97M | -$61.27M | -$54.15M | -$48.13M | -$41.51M | -$14.92M |
| Purchases of Investments | -$72.49M | -$86.28M | -$112.9M | -$186.6M | -$221.8M | -$68.36M |
| **Investing Cash Flow** | $35.22M | $66.25M | -$43.73M | -$25.74M | -$139.0M | -$25.28M |
| **Financing Cash Flow** | $214K | $1.14M | $368K | $562K | $327.4M | $75.90M |
| **Net Change in Cash** | -$15.26M | $8.25M | -$95.08M | -$70.98M | $149.2M | $36.62M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$15.64M | -$14.47M | -$14.70M | -$13.78M | -$13.57M | -$15.03M | -$16.61M | -$17.59M |
| Depreciation & Amortization | $200K | $300K | $334K | $400K | $400K | $400K | $465K | $457K |
| Stock-Based Compensation | $1.29M | $1.16M | $1.36M | $1.47M | $1.50M | $1.71M | $2.17M | $3.12M |
| Change in Payables | $152K | -$304K | $200K | $2.0K | -$20K | $80K | -$131K | -$543K |
| **Operating Cash Flow** | -$13.28M | -$13.73M | -$13.10M | -$12.38M | -$11.03M | -$13.35M | -$13.94M | -$14.31M |
| Capital Expenditure | -$1.45M | -$454K | -$510K | -$244K | -$418K | -$396K | -$219K | -$254K |
| **Free Cash Flow** | -$14.73M | -$14.18M | -$13.61M | -$12.62M | -$11.45M | -$13.75M | -$14.16M | -$14.56M |
| Purchases of Investments | -$9.00M | -$17.43M | -$11.06M | -$33.72M | -$27.49M | -$4.38M | -$6.90M | -$26.88M |
| **Investing Cash Flow** | $10.44M | $12.02M | $14.23M | $787K | $452K | $14.47M | $19.51M | $37.11M |
| **Financing Cash Flow** | $26K | $244K | $1.10M | $101K | $0 | $95K | $18K | $440K |
| **Net Change in Cash** | -$2.82M | -$1.46M | $2.24M | -$11.49M | -$10.58M | $1.22M | $5.59M | $23.24M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -37.6% | -33.9% | -24.0% | -18.4% | -13.8% | -- |
| Return on Assets (ROA) | -30.9% | -29.2% | -20.8% | -16.5% | -12.6% | -18.4% |
| Current Ratio | 13.33x | 17.40x | 19.39x | 27.57x | 60.09x | 25.73x |
| Quick Ratio | 13.00x | 17.02x | 19.01x | 27.17x | 59.48x | 25.43x |
| Debt to Equity | 0.19x | 0.15x | 0.13x | 0.10x | 0.08x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -50.3% | -43.1% | -39.5% | -37.6% | -37.1% | -36.3% | -35.3% | -33.9% |
| Return on Assets (ROA) | -39.3% | -34.6% | -32.1% | -30.9% | -31.3% | -30.8% | -30.2% | -29.2% |
| Current Ratio | 9.25x | 10.14x | 11.85x | 13.33x | 14.95x | 18.52x | 17.36x | 17.40x |
| Quick Ratio | 9.16x | 10.07x | 11.81x | 13.00x | 14.63x | 18.18x | 17.02x | 17.02x |
| Debt to Equity | 0.23x | 0.21x | 0.20x | 0.19x | 0.16x | 0.16x | 0.15x | 0.15x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
